Spreading Pigweed Allergy: The Ground-Level Weed You Never See Coming

Spreading pigweed is Amaranthus blitoides, a mat-forming annual weed that grows flat along the ground across western and central US roadsides, disturbed soils, and agricultural margins. Despite reaching only 6 to 12 inches in height, it spreads laterally up to 3 feet and produces wind-dispersed pollen that reaches respiratory height during its August through October bloom period. The pollen triggers IgE-mediated allergic reactions in sensitized individuals through proteins homologous to Ama r 1 (an Ole e 1-like protein) characterized in the related rough pigweed species. Because the plant is low-growing and blends into the landscape, many patients never identify it as a pollen source despite reacting to it annually.

Spreading pigweed (Amaranthus blitoides) is defined by its mat-forming, ground-hugging growth habit — it spreads laterally rather than growing upright. Rough pigweed (A. retroflexus) grows 3 to 6 feet tall and is the reference species with characterized allergens (Ama r 1, Ama r 2). Tumble pigweed (A. albus) grows upright, then dries and breaks free at senescence to form tumbleweeds. Palmer amaranth (A. palmeri) is the most aggressive species, growing 2 to 5 inches per day in agricultural fields. All share the same genus-level allergen cross-reactivity, meaning an Amaranthus allergy test covers all species through the same rough pigweed extract.

Yes, spreading pigweed allergy is almost always part of a broader fall weed sensitization rather than a single-species reaction. Because A. blitoides pollen is microscopically identical to lamb's quarters (Chenopodium album), both are counted together as the 'Cheno/Am' fraction on pollen monitoring reports. Patients cannot determine from symptoms alone whether their fall reaction is driven by spreading pigweed, lamb's quarters, rough pigweed, Russian thistle, or kochia — all Amaranthaceae weeds co-pollinating in the same August through October window. Allergy testing can confirm Amaranthaceae sensitization using rough pigweed extract, but cannot differentiate between specific co-pollinators. This is clinically acceptable because immunotherapy covers the genus through cross-reactive proteins.

The standard test is specific IgE blood testing or skin prick testing using Amaranthus retroflexus (rough pigweed) extract, designated w14 in ImmunoCAP panels. No A. blitoides-specific test exists, but the cross-reactive Ama r 1 protein is shared across the genus, making rough pigweed extract the accepted diagnostic surrogate. Testing is typically performed as part of a broader seasonal weed panel that also includes lamb's quarters (w10), Russian thistle (w11), and kochia (w17) to characterize the full Amaranthaceae sensitization profile. A board-certified allergist interprets results in the context of symptom timing and geographic exposure to confirm clinical relevance.

Spreading pigweed pollen season runs from approximately August through October across western and central US regions where A. blitoides is prevalent. Pollen release peaks on dry, warm, windy mornings — conditions common in the arid and semi-arid western landscapes where the plant thrives. The season overlaps extensively with other Amaranthaceae pollinators: lamb's quarters, Russian thistle, kochia, and rough pigweed all release pollen during this same window, compounding the total Amaranthaceae exposure. Climate change has progressively pushed the onset earlier and extended the season later, with pollen seasons across the US starting approximately 20 days earlier than in 1990 according to Anderegg et al., 2021.

They are different species but share extensive allergen cross-reactivity through common Amaranthaceae family proteins. Spreading pigweed is Amaranthus blitoides (family Amaranthaceae, genus Amaranthus), while lamb's quarters is Chenopodium album (family Amaranthaceae, genus Chenopodium). Their pollen is microscopically indistinguishable and counted together as the 'Cheno/Am' fraction in aerobiology. Cross-reactive Ole e 1-like and profilin proteins are shared across these genera, meaning patients sensitized to one are frequently sensitized to both. Treatment with immunotherapy targeting both genera provides comprehensive Amaranthaceae coverage for patients reacting to multiple species in this family.

Yes, Amaranthaceae pollen including spreading pigweed is a documented trigger for asthma exacerbations in sensitized individuals with co-existing asthma. The fall weed pollen season in the western US coincides with high ambient Cheno/Am counts from multiple co-pollinating Amaranthaceae species, creating a compounded airway allergen burden for asthmatic patients. Studies on allergic asthma consistently show that weed pollen sensitization is associated with increased asthma emergency department visits and rescue inhaler use during peak season. Patients with spreading pigweed sensitization and asthma should optimize controller medications before the fall season and discuss immunotherapy with an allergist to reduce the underlying pollen burden driving airway inflammation.

Spreading pigweed pollen season typically lasts 8 to 12 weeks, running from August through October in most western and central US regions. The season ends with the first hard frost that kills annual A. blitoides plants. In the warmest, most arid parts of the Southwest, the season may begin in late July and extend into November. Year to year variation is significant: wet spring and early summer conditions that support vigorous plant growth typically precede higher fall pollen counts. Climate change has measurably extended the US weed pollen season over the past three decades, with Anderegg et al. documenting a 20-day earlier season start and 10-day longer duration since 1990.

Yes, allergen immunotherapy targeting Amaranthaceae antigens can meaningfully reduce spreading pigweed allergy symptoms. Because no species-specific extract exists for A. blitoides, immunotherapy uses Amaranthus retroflexus (rough pigweed) extract to cover the genus through shared cross-reactive proteins, often combined with lamb's quarters, Russian thistle, and kochia to address the full fall weed co-sensitization pattern. Both subcutaneous immunotherapy (allergy shots) and sublingual immunotherapy (SLIT drops) have demonstrated efficacy for weed pollen allergic rhinitis. Clinical trials show 60 to 80 percent of patients achieve significant and durable symptom reduction over a 3 to 5 year treatment course, with benefit persisting after treatment completion.

Complete avoidance of outdoor activities is rarely necessary or practical during spreading pigweed season, but strategic timing of outdoor time can meaningfully reduce pollen exposure. Pollen counts are highest on dry, warm, windy mornings between 6 a.m. and noon — scheduling high-exertion outdoor activities for late afternoon or post-rain days reduces exposure significantly. Wearing sunglasses to protect eyes from airborne pollen and showering after outdoor time to remove surface pollen are practical measures that reduce cumulative exposure. For patients with severe symptoms or asthma triggered by fall weed pollen, an allergist can provide a personalized activity guidance plan based on local Cheno/Am pollen thresholds.